These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21182995)

  • 1. Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein.
    Iankov ID; Haralambieva IH; Galanis E
    Vaccine; 2011 Feb; 29(8):1710-20. PubMed ID: 21182995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles virus expressed Helicobacter pylori neutrophil-activating protein significantly enhances the immunogenicity of poor immunogens.
    Iankov ID; Federspiel MJ; Galanis E
    Vaccine; 2013 Oct; 31(42):4795-801. PubMed ID: 23948230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein.
    Iankov ID; Penheiter AR; Carlson SK; Galanis E
    J Immunol Methods; 2012 Oct; 384(1-2):1-9. PubMed ID: 22750540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus.
    Iankov ID; Allen C; Federspiel MJ; Myers RM; Peng KW; Ingle JN; Russell SJ; Galanis E
    Mol Ther; 2012 Jun; 20(6):1139-47. PubMed ID: 22334023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.
    Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of an oral recombinant DNA vaccine from H pylori neutrophil activating protein and its immunogenicity.
    Sun B; Li ZS; Tu ZX; Xu GM; Du YQ
    World J Gastroenterol; 2006 Nov; 12(43):7042-6. PubMed ID: 17109503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study.
    Malfertheiner P; Schultze V; Rosenkranz B; Kaufmann SH; Ulrichs T; Novicki D; Norelli F; Contorni M; Peppoloni S; Berti D; Tornese D; Ganju J; Palla E; Rappuoli R; Scharschmidt BF; Del Giudice G
    Gastroenterology; 2008 Sep; 135(3):787-95. PubMed ID: 18619971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor.
    Satin B; Del Giudice G; Della Bianca V; Dusi S; Laudanna C; Tonello F; Kelleher D; Rappuoli R; Montecucco C; Rossi F
    J Exp Med; 2000 May; 191(9):1467-76. PubMed ID: 10790422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design of vaccines against Helicobacter pylori and their development.
    Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
    Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy.
    Rossi G; Ruggiero P; Peppoloni S; Pancotto L; Fortuna D; Lauretti L; Volpini G; Mancianti S; Corazza M; Taccini E; Di Pisa F; Rappuoli R; Del Giudice G
    Infect Immun; 2004 Jun; 72(6):3252-9. PubMed ID: 15155627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study.
    Malfertheiner P; Selgrad M; Wex T; Romi B; Borgogni E; Spensieri F; Zedda L; Ruggiero P; Pancotto L; Censini S; Palla E; Kanesa-Thasan N; Scharschmidt B; Rappuoli R; Graham DY; Schiavetti F; Del Giudice G
    Lancet Gastroenterol Hepatol; 2018 Oct; 3(10):698-707. PubMed ID: 30042064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection.
    Ghasemi A; Mohammad N; Mautner J; Taghipour Karsabet M; Amani J; Ardjmand A; Vakili Z
    Vaccine; 2018 Aug; 36(34):5124-5132. PubMed ID: 30041879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice.
    Zhou Z; Dong H; Huang Y; Yao S; Liang B; Xie Y; Long Y; Mai J; Gong S
    J Med Microbiol; 2017 Jan; 66(1):83-89. PubMed ID: 27930268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
    Liu M; Zhong Y; Chen J; Liu Y; Tang C; Wang X; Zhang Y; Wang P; Logan SM; Chen W; Wei B
    Vaccine; 2020 Mar; 38(14):3031-3041. PubMed ID: 32139315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.